Actinogen Medical Ltd has released a press release.
Actinogen Ethics Committee approval for XanaMIA study
Filed with ASX ·
6ix hasn’t read this filing yet.
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Response to ASX Price Query
- Strategic Update & Teleconference Call Notification
- Actinogen CEO assumes Managing Director position
- Actinogen appoints Dr Steven Gourlay as CEO
- ACW raises an addtional $3.55m under a Shortfall Placement
Later from Actinogen Medical
- Clinical progress for XanaMIA trial
- Actinogen receives positive Pre-IND FDA advice for FXS
- First Patient Enrolled in XanaMIA trial
- Actinogen completes global patent family grant
- Actinogen Medical FY21 Results- Progressing the Pipeline
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical